Anticoagulants, antiplatelets, and thrombolytics / (Record no. 30457)

MARC details
000 -LEADER
fixed length control field 03084cam a22005054a 4500
003 - CONTROL NUMBER IDENTIFIER
control field CUTN
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190829153639.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 030730s2004 njua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1588290832 (alk. paper)
041 ## - LANGUAGE CODE
Language English
042 ## - AUTHENTICATION CODE
Authentication code pcc
060 #0 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W1
Item number ME9616JM v.93 2003
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QZ 170
Item number A629 2003
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.718
Edition number 22
Item number MOU
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Mousa, Shaker A.
245 00 - TITLE STATEMENT
Title Anticoagulants, antiplatelets, and thrombolytics /
Statement of responsibility, etc edited by Shaker A. Mousa.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Totowa, N.J. :
Name of publisher, distributor, etc Humana Press,
Date of publication, distribution, etc c2004.
300 ## - PHYSICAL DESCRIPTION
Extent x, 307 p. :
Other physical details ill. ;
Dimensions 24 cm.
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE
Title Methods in molecular medicine ;
Volume number/sequential designation 93
505 ## - FORMATTED CONTENTS NOTE
Title Highlights of latest advances in antithrombotics <br/>
-- Antiplatelet, anticoagulant, and thrombolytic drug interactions <br/>
-- Evaluation of platelet antagonists in in vitro flow models of thrombosis
-- Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases <br/>
-- Are low molecular weight heparins the same?
-- Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia <br/>
-- Laboratory methods for heparin-induced thrombocytopenia<br/>
-- Factor Xa inhibitors
-- Tissue factor/VIIa in thrombosis and cancer
-- Tissue factor pathway inhibitor in thrombosis and beyond
-- Cell adhesion molecules: potential therapeutic and diagnostic implications<br/>
-- Development and applications of animal models of thrombosis
-- A survey of venous thrombosis models
-- Arixtra (fondaparinux sodium)
-- Oral thrombin inhibitor ximelagatran
-- Pharmacogenomics and coagulation disorders
-- Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism
520 ## - SUMMARY, ETC.
Summary, etc <br/>"During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new Read more...
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Anticoagulants (Medicine)
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Blood platelets.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Thrombolytic therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fibrinolytic agents.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Anticoagulants
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Thrombolytic Therapy
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fibrinolytic Agents
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Heparin
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Platelet Aggregation Inhibitors
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Thrombocytopenia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mousa, Shaker A.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type General Books
856 41 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/toc/ecip047/2003017231.html">http://www.loc.gov/catdir/toc/ecip047/2003017231.html</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/enhancements/fy0826/2003017231-d.html">http://www.loc.gov/catdir/enhancements/fy0826/2003017231-d.html</a>
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision therapeutic use.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision methods.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision therapeutic use.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision therapeutic use.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision therapeutic use.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
General subdivision drug therapy.
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Table of contents
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ecip
f 20
g y-gencatlg
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Location Shelving location Date of Cataloging Total Checkouts Total Renewals Full call number Barcode Date last seen Date checked out Price effective from Koha item type
    Dewey Decimal Classification     Non-fiction CUTN Central Library CUTN Central Library Medicine, Technology & Management 29/08/2019 2 2 615.718 MOU 38249 17/05/2022 22/04/2022 29/08/2019 General Books

Powered by Koha